Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia

X-linked sideroblastic anemia (XLSA) is associated with mutations in the erythroid-specific δ-aminolevulinic acid synthase (ALAS2) gene. Treatment of XLSA is mainly supportive, except in patients who are pyridoxine responsive. Female XLSA often represents a late onset of severe anemia, mostly relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Morimoto, Yuki, Chonabayashi, Kazuhisa, Kawabata, Hiroshi, Okubo, Chikako, Yamasaki-Morita, Makiko, Nishikawa, Misato, Narita, Megumi, Inagaki, Azusa, Nakanishi, Kayoko, Nagao, Miki, Takaori-Kondo, Akifumi, Yoshida, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Red Cells, Iron, and Erythropoiesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864662/
https://www.ncbi.nlm.nih.gov/pubmed/34781359
http://dx.doi.org/10.1182/bloodadvances.2021005664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864662/
https://www.ncbi.nlm.nih.gov/pubmed/34781359
http://dx.doi.org/10.1182/bloodadvances.2021005664

Ejemplares similares